Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery

Abstract

A DCB-based treatment approach for left anterior descending revascularization allows a significantly reduced stent burden, thereby potentially limiting target lesion failure risk at midterm follow-up.